JPS63225340A - リポキシゲナーゼ抑制化合物 - Google Patents

リポキシゲナーゼ抑制化合物

Info

Publication number
JPS63225340A
JPS63225340A JP63031682A JP3168288A JPS63225340A JP S63225340 A JPS63225340 A JP S63225340A JP 63031682 A JP63031682 A JP 63031682A JP 3168288 A JP3168288 A JP 3168288A JP S63225340 A JPS63225340 A JP S63225340A
Authority
JP
Japan
Prior art keywords
ethyl
phenyl
hydroxy
group
phenylethoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP63031682A
Other languages
English (en)
Japanese (ja)
Inventor
ジェイムス・ビィ・サマーズ・ジュニア
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of JPS63225340A publication Critical patent/JPS63225340A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • C07C275/20—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C275/24—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/64—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups singly-bound to oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
JP63031682A 1987-02-10 1988-02-10 リポキシゲナーゼ抑制化合物 Pending JPS63225340A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/012,978 US4897422A (en) 1987-02-10 1987-02-10 Lipoxygenase inhibiting compounds
US012,978 1987-02-10

Publications (1)

Publication Number Publication Date
JPS63225340A true JPS63225340A (ja) 1988-09-20

Family

ID=21757673

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63031682A Pending JPS63225340A (ja) 1987-02-10 1988-02-10 リポキシゲナーゼ抑制化合物

Country Status (9)

Country Link
US (1) US4897422A (enExample)
EP (1) EP0279281B1 (enExample)
JP (1) JPS63225340A (enExample)
KR (1) KR950011120B1 (enExample)
AU (1) AU600336B2 (enExample)
CA (1) CA1304391C (enExample)
DE (1) DE3873936T2 (enExample)
ES (1) ES2044982T3 (enExample)
GR (1) GR3006232T3 (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5157053A (en) * 1985-02-04 1992-10-20 G. D. Searle & Co. Bicycloalky, tricycloalkyl, azabicycloalkyl, and azatricycloalkyl thio amides used to treat inflammation, allergy, asthma and skin disorders
CA1336099C (en) * 1987-04-24 1995-06-27 James B. Summers, Jr. Urea based lipoxygenase compounds
US5068251A (en) * 1988-12-16 1991-11-26 Abbott Laboratories Lipoxygenase inhibiting compounds
US5096919A (en) * 1989-01-05 1992-03-17 Ciba-Geigy Corporation Pyrrolylphenyl-substituted hydroxamic acid derivatives
US5175183A (en) * 1989-02-01 1992-12-29 Abbott Laboratories Lipoxygenase inhibiting compounds
ATE96427T1 (de) * 1989-02-03 1993-11-15 Wellcome Found Entzuendungshemmende arylderivate.
US4960787A (en) * 1989-02-06 1990-10-02 Ciba-Geigy Corporation Certain pyrrolyl-substituted hydroxamic acid derivatives
US5075330A (en) * 1989-05-26 1991-12-24 Warner-Lambert Co. N-hydroxyamide, N-hydroxythioamide, N-hydroxyurea, and N-hydroxythiourea derivatives of selected NSAIDS as antiinflammatory agents
US5112846A (en) * 1989-05-26 1992-05-12 Warner-Lambert Company N-hydroxyamide, N-hydroxythioamide, hydroxyurea, and N-hydroxythiourea derivatives of selected nsaids as antiinflammatory agents
US4981865A (en) * 1989-05-26 1991-01-01 Warner-Lambert Co. N-hydroxyamide, N-hydroxythioamide, hydroxyurea, and N-hydroxythiourea derivatives of selected nsaids as antiinflammatory agents
JP3065636B2 (ja) * 1989-06-29 2000-07-17 塩野義製薬株式会社 ［ジ―ｔｅｒｔ―ブチル（ヒドロキシ）フェニルチオ］置換ヒドロキサム酸誘導体
US5120752A (en) * 1989-12-28 1992-06-09 Abbott Laboratories Cyclopropyl derivative lipoxygenase inhibitors
US5220059A (en) * 1990-04-19 1993-06-15 Abbott Laboratories Lipoxygenase-inhibiting compounds derived from non-steroidal antiinflammatory carboxylic acids
KR900016822A (ko) * 1990-04-20 1990-11-14 하라 레이노스께 슬라이드 프로젝터
GB9012252D0 (en) * 1990-06-01 1990-07-18 Lilly Industries Ltd Pharmaceutical compounds
DE4023742A1 (de) * 1990-07-26 1992-01-30 Gruenenthal Gmbh Substituierte phenylacetylene, diese enthaltende arzneimittel und verfahren zur herstellung dieser verbindungen und arzneimittel
US5130485A (en) * 1991-04-23 1992-07-14 Eli Lilly And Company N-hydroxy-N-(3-(2-substituted phenyl)prop-2-enyl)ureas and thioureas useful as 5-lipoxygenase inhibiting agents
US5214204A (en) * 1991-07-19 1993-05-25 Abbott Laboratories Arylamidoalkyl-n-hydroxyurea compounds having lipoxygenase inhibitory activity
US5183818A (en) * 1991-08-27 1993-02-02 Abbott Laboratories Arylalkylether and arylalkylthioether inhibitors of lipoxygenase enzyme activity
US5234933A (en) * 1991-10-31 1993-08-10 Board Of Governors Of Wayne State University And Vanderbilt University Cyclic hydroxamic acids
DE4210332C1 (enExample) * 1992-03-30 1993-07-15 Gruenenthal Gmbh, 5100 Aachen, De
DE4308535A1 (de) * 1992-03-30 1993-10-07 Volkswagen Ag Brennkraftmaschine mit einem desaktivierbaren Ladungswechselventil
WO1995002575A1 (en) * 1993-07-14 1995-01-26 Smithkline Beecham Corporation 5-lipoxygenase inhibitors
US5468760A (en) * 1993-11-08 1995-11-21 American Home Products Corporation Aralkyl-N-hydroxyureas as inhibitors of 5-lipoxygenase and oxidation of low density lipoprotein
US5459154A (en) * 1993-11-08 1995-10-17 American Home Products Corporation N-hydroxyureas as 5-lipoxygenase inhibitors and inhibitors of oxidative modification of low density lipoprotein
US5428048A (en) * 1993-11-08 1995-06-27 American Home Products Corporation Aryl-N-hydroxyureas as inhibitors of 5-lipoxygenase and anto-arteriosclerotic agents
US5612377A (en) * 1994-08-04 1997-03-18 Minnesota Mining And Manufacturing Company Method of inhibiting leukotriene biosynthesis
DK3054936T5 (da) 2013-10-10 2024-03-18 Eastern Virginia Medical School 4-((2-hydroxy-3-methoxybenzyl)amino) benzensulfonamid derivater som 12-lipoxygenase inhibitorer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3855242A (en) * 1967-12-15 1974-12-17 Aspro Nicholas Ltd Benzo{8 b{9 thienyl-alkyl-guanidines
US3890377A (en) * 1968-08-15 1975-06-17 Lilly Co Eli 3-Substituted phenylalkanohydroxamic acids
FR2068420A1 (en) * 1969-10-28 1971-08-27 Roussel Uclaf Benzothienyl methyl guanidine antihypertensive
GB1382282A (en) * 1972-06-01 1975-01-29 Labaz Benzo b thiophene compounds and processes for preparing the same
HU201300B (en) * 1985-03-16 1990-10-28 Wellcome Found Process for production of derivatives of aryl and medical compositions containing them as active substance
IE59397B1 (en) * 1985-03-16 1994-02-23 Wellcome Found New aryl derivatives
US4604407A (en) * 1985-04-04 1986-08-05 E. R. Squibb & Sons, Inc. Hydroxamates

Also Published As

Publication number Publication date
AU1143288A (en) 1988-08-11
DE3873936D1 (de) 1992-10-01
ES2044982T3 (es) 1994-01-16
DE3873936T2 (de) 1993-04-15
AU600336B2 (en) 1990-08-09
CA1304391C (en) 1992-06-30
KR950011120B1 (ko) 1995-09-28
EP0279281B1 (en) 1992-08-26
KR880009910A (ko) 1988-10-05
GR3006232T3 (enExample) 1993-06-21
EP0279281A2 (en) 1988-08-24
EP0279281A3 (en) 1989-05-03
US4897422A (en) 1990-01-30

Similar Documents

Publication Publication Date Title
JPS63225340A (ja) リポキシゲナーゼ抑制化合物
EP0292699B1 (en) Urea based lipoxygenase inhibiting compounds
EP0178874B1 (en) Alkylsulfonamidophenylalkylamines
EP0091468B1 (en) (1-(2-benzoxazolyl)hydrazino)alkyl nitrile derivatives
HU201300B (en) Process for production of derivatives of aryl and medical compositions containing them as active substance
JPH03500887A (ja) フランおよびピロール含有リポキシゲナーゼ抑制化合物
US4407803A (en) Antiinflammatory 1-(quinolinyl)-2-pyrazoline derivatives
US5095039A (en) Diphenylsulfide compound and use
CA2552565A1 (fr) Derives de type aryloxyalkylcarbamates, leur preparation et leur application en therapeutique
CA2539849A1 (fr) Derives d'arylalkylcarbamates, leur preparation et leur application en therapeutique
US4822811A (en) Carbazole lipoxygenase inhibiting compounds, compositions and use
FR2679555A1 (fr) Nouveaux derives de l'uree, leur preparation et leur application en therapeutique.
JPS6216942B2 (enExample)
US5026729A (en) Lipoxygenase inhibiting compounds
JPH04503074A (ja) リポキシゲナーゼ阻止化合物
EP0034116A2 (en) N-(3-phenoxy-2-hydroxypropyl)benzimidazole-1-alkanamines
JPH032116A (ja) ベンゼン誘導体、その調製およびこれを含有する薬学的組成物
EP0348257A2 (fr) Nouveaux dérivés d'(hétéro)aryl diazole, leur procédé de préparation et leur application en thérapeutique
CA1139763A (fr) Procede d'obtention de nouveaux aryltrifluoroethanols
US4296120A (en) (Carboxy-oxo-pyrrolidino)phenylalkenamides and esters thereof as SRS-A antagonists
EP0083222B1 (en) New quinolylacetic acid compounds and pharmaceutical compositions containing them
US3845123A (en) Phenoxypropanolamine therapeutic agents
US5001140A (en) Cycloalkylthiazoles
US4370339A (en) Method for treating inflammatory conditions
JPH0629264B2 (ja) ２‐アミノ‐５‐ヒドロキシ‐４‐ピリミドン